Search Results 2331-2340 of 24013 for Periods

  1. Clinical Trials - RNS® System RESPONSE Study

    ... periods, with no 30-day period with less than two seizures per subject and/or parent/caregiver report. Subject failed treatment with a minimum of two anti ...

  2. Pediatrics Clinical Trials - Medical Professionals

    ... period followed by a 52-week, open-label extension period. A Registry for Children Treated with Proton Radiation Therapy. Rochester, Minn. The purpose of the ...

  3. Clinical trials - Oncology (Medical)

    The five year follow-up period will ensure robust survival data for correlations with clinical, tumor, and treatment variables. The target of 2,500 patients is ...

  4. Immunosuppressive Drugs Clinical Trials - Mayo Clinic Research

    ... period of 48 weeks. All patients will be eligible to continue in an open-label extension trial of L-CsA following completion of BOSTON-2. BT – L-CsA – 301 ...

  5. A Study to Evaluate the Safety and Feasibility of Intra-articular Transplantation of Autologous Adipose Derived Stromal Vascular Fraction (SVF) for Treatment of Osteoarthritis of the Knee - Mayo Clinic

    ... period of 1 year following completion of the drug treatment cycle. Females of childbearing potential are defined as premenopausal and not surgically ...

  6. Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism - Mayo Clinic

    History of any other cancer other than thyroid cancer (except basal cell skin cancer or squamous cell skin cancer) who have not been disease-free for a period ...

  7. Bariatric surgery - Mayo Clinic

    Bariatric surgery can be a helpful weight loss tool — but it's not for everyone. Learn about available procedures and the risks and results of surgery.

  8. A Study to Evaluate ALZT-OP1a in Subjects with Mild-to-Moderate Amyotrophic Lateral Sclerosis - Mayo Clinic

    ... period, to evaluate the effects of ALZT-OP1a (cromolyn) on functional changes in subjects with mild-moderate stage ALS by using the ALS Functional Rating ...

  9. A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Subjects With T-cell Prolymphocytic Leukemia - Mayo Clinic

    Laboratory values meeting the following criteria within the screening period prior to the first dose of study drug: alanine aminotransferase (ALT)/aspartate ...

  10. A Study to Evaluate DS-8201a Combined with Olaparib in HER2-Expressing Cancers with Expansion in Endometrial Cancer Patients Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial Cancer - Mayo Clinic

    Male subjects must not freeze or donate sperm starting at screening and throughout the study period, and at least 4 months after the final study drug ...